Back to Research Hub
Olema Pharmaceuticals, Inc.
OLMA
$11.49-0.10 (-0.86%)
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc.
StreetsValue research for Olema Pharmaceuticals, Inc. (OLMA)
Members get the full report for Olema Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.